Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. In this webinar, the expert speakers will focus on how site augmentation brings life-saving treatments to market faster through scalable, flexible decentralized solutions for on-site, remote or hybrid models.
This dynamic discussion will explore today’s demanding research landscape, where understaffed sites struggle to keep pace with intricate trials and patient-focused solutions being integrated to transform clinical trial success. Customizable site augmentation programs offer practical answers for streamlining clinical trials, and matching dedicated clinical research professionals to a site’s unique needs alleviates burdens and empowers existing staff.
Discover how seamlessly integrating on-site or remote personnel to manage administrative tasks or study-specific services can free up staff to focus on patient care and engagement. This approach leads to faster enrollment and a superior patient experience.
Register for this webinar today to gain invaluable insights into decentralized services for conducting clinical trials and supporting patients in a new age of medicine.
Speakers
Robin Marcus, Head of Global Decentralized Trials Market Development, Marken
Robin Marcus is Marken’s Head of Global Decentralized Trials Market Development and has over 30 years of experience driving business optimization, championing innovation and generating aggressive revenue growth. She has successfully launched new products, divisions and companies that have exceeded corporate goals and built collaborative, high-performance teams to deliver results across the healthcare enterprise.
For the past 10 years, Robin has focused on the global expansion of decentralized clinical trial (DCT) services, including mobile clinical services, e-consent, eCOA/ePRO, telemedicine and ambulatory devices. Robin’s clinical background and experience working in pharma and biotech industries is critical in assessing and developing DCT strategies at the company, portfolio and study level.
Prior to joining Marken, Robin was the Chief Strategy Officer at GlobalCare Clinical Trials and later an Executive Director focused on DCT Implementation during an acquisition by LabCorp Drug Development. Her enthusiasm as a leader and dynamic communicator has built strong relationships with industry stakeholders, including boards, biotech and pharma companies, physicians, community agencies, colleagues and patients.
Message Presenter
Jimmy Bechtel, Vice-President of Site Engagement, Society for Clinical Research Sites
Jimmy Bechtel, VP of Site Engagement, SCRS, leverages his clinical research experience from both site and sponsor perspectives. With a diverse background as a Data Specialist, Patient Recruiter and Operations Manager, he fosters a site-centric environment and facilitates collaboration between sites and major sponsors.
Jimmy spearheads site-facing initiatives, collaborates with industry partners for partnership programs and oversees the membership department’s site-focused operations, design and marketing efforts.
Message PresenterWho Should Attend?
This webinar will appeal to professionals who are involved with:
- Pharmaceutical development
- Biotechnology companies
- Central labs
- Contract manufacturing organizations
- Contract research organizations
- CDMOs
What You Will Learn
Attendees will learn about:
- Future-focused strategies for sites and sponsors to enhance patient outcomes through an agile and resilient supply chain network
- Maximizing site augmentation to alleviate cost pressures, resource shortages and ensure patient expectations for customization and convenience
- Developing cross-organizational communication and collaboration channels with all shared stakeholders to drive trial success
- Leveraging innovative tech solutions and digital tools such as telehealth, AI, remote monitoring and personalized packaging for real-time data sharing and patient input
Xtalks Partner
Marken
Marken, UPS Healthcare’s clinical subsidiary, includes BOMI Group and Polar Speed, staffing 199 locations and 10,000+ employees globally. Offering a GMP-compliant depot network in 60 locations, Marken leads in Direct-to-Patient services, biological sample shipments, and kit production. Their 2,400+ staff manage 154,000 monthly shipments in 220+ countries and have arranged 15,000+ home healthcare visits. Services like cell and gene supply chain, ancillary material sourcing, shipment lane verification, and GDP consultancy solidify Marken’s unique industry position.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account